This vaccine is a combination of the licensed R21/Matrix-M P. falciparum vaccine and Rvx21 (a P. vivax version of R21/Matrix-M) developed by the University of Oxford, UK.
The Rvx21 vaccine is a virus-like particle with broad strain coverage of P. vivax circumsporozoite protein. It is designed and manufactured similarly to R21/Matrix-M vaccine.